Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-20

FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA has approved a supplemental application for TRACLEER (bosentan) from Actelion Pharmaceuticals US, Inc. to modify or expand its labeling. Tracleer is used to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRACLEER (bosentan)

Snippet

SUPPL AP for TRACLEER (BOSENTAN)